Phase 2 N=33 Remodulin® to Oral Treprostinil Transition
Pulmonary Arterial Hypertension
Primary: Number of Participants That Were Succesfully Transitioned From Parenteral Remodulin to UT-15C. — 31 participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=379 Observational Study Evaluating Outcomes of Hip Arthroplasty Using Tornier Dual Mobility Acetabular Cup
Primary Osteoarthritis · Post-traumatic Osteoarthritis of Hip Nos · Femur Head Necrosis
Primary: Number of Participants With an Implant Dislocation After Surgery — 2 participants
Phase 3 N=7,028 BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME).
Diabetes Mellitus, Type 2
Primary: Time to the First Occurrence of Any of the Following Adjudicated Components of the Primary Composite Endpoint (3-point MACE): CV Death (Including Fatal Stroke and Fatal…
Phase 3 N=88 Aripiprazole Once-monthly in Patients With Schizophrenia
Schizophrenia
Primary: Safety and Tolerability — 65 number of events
Phase 3 N=731 Reduction in the Occurrence of Center-Involved Diabetic Macular Edema
Diabetic Retinopathy
Primary: Mean Duration of Definite Center of Macula-involved Diabetic Macular Edema (DME) — 1.72; 1.69 months per participant — p=0.969
N/A N=56 Impact of Vitamin D Therapies on Chronic Kidney Disease
Chronic Kidney Disease (CKD) · End-stage Renal Disease (ESRD)
Primary: Monocyte Protein Expression — 34110; 38540; 1359; 1360 relative fluorescence units
Phase 3 N=37 Effectiveness of Etanercept for Idiopathic Pneumonia Syndrome Following Stem Cell Transplantation (BMT CTN 0403)
Pneumonia · Idiopathic Pneumonia Syndrome
Primary: Response Rate — 62.5; 66.7 percentage of participants
N/A N=42 A Study to Investigate the Effects of a New Treatment in Patients With Chronic Pain
Peripheral Neuropathies
Primary: Patient 's Change From Baseline of Pain Severity as Measured by the Weekly Means of the Daily Average Pain Scores (APS) During 4 Weeks of Treatment — 0.87; 0.5 units on…
N/A N=18 A Feasibility Study Evaluating the Use of a Non-invasive Ventilation Mask
Noninvasive Ventilation · Respiratory Insufficiency
Primary: Clinician Assessment of Use With a Questionnaire — 5; 4 units on a scale
Phase 4 N=120 Treating Acutely Agitated Patients With Asenapine Sublingual Tablets
Agitation
Primary: Positive and Negative Syndrome Scale - Excited Component — 7.86; 14.93 PANSS SCORE
Phase 2 N=43 Blinded Study of Topical Investigational Lotion Vs. Approved Cream in Treatment of Plaque Psoriasis
Plaque Psoriasis
Primary: Adrenal Suppression Potential — 16; 18; 5; 3 participants
Phase 3 N=66 Prolotherapy for the Treatment of Chronic Lateral Epicondylitis
Lateral Epicondylitis · Tennis Elbow
Primary: McGill Pain Questionnaire — 16.6; 15.7; 14.3; 8.2 units on a scale
N/A N=14 MRI Study With Ferumoxytol in Assessing Early Response in Patients With Glioblastoma Multiforme Receiving Temozolomide and Radiation Therapy
Adult Brain Glioblastoma
Primary: Mean Cerebral Blood Volume (CBV) — 2.5; 1.38; 2.36 mL/g — p=.003
Phase 2 N=12 Safety and Efficacy Study of Mini-Dose Glucagon (G-Pen Mini) in Patients With Type 1 Diabetes
Hypoglycemia
Primary: Serious Adverse Events — 0; 0; 0 participants
N/A N=180 Prevention of Postoperative Nausea and Vomiting (PONV) in Surgical Patients
Postoperative Nausea and Vomiting
Primary: Incidence of Postoperative Nausea and Vomiting — 34.4; 29.8; 12.5; 7 percentage of participants — p=>0.76